Mylan Launches Generic Myfortic® Delayed-Release Tablets – MarketWatch
|
Mylan Launches Generic Myfortic® Delayed-Release Tablets
MarketWatch PITTSBURGH, Jan. 9, 2014 /PRNewswire via COMTEX/ — Mylan Inc. (NASDAQ:MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is … Mylan Launches Generic Myfortic(R) Delayed-Release TabletsThe Providence Journal Mylan Launches Generic MyforticMonthly Prescribing Reference |
